drugset / Trial / NCT03560427

Duloxetine Potentiates the Analgesic Efficacy of Intrathecal Morphine

NCT03560427

Completed 60 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

Duloxetine is a serotonin-norepinephrine reuptake inhibitor primarily used for treatment of major depression and anxiety. Duloxetine also has been used in the treatment of chronic pain conditions, such as osteoarthritis and musculoskeletal pain. There are few studies examining its effect for acute pain. The objective of this study is to evaluate the analgesic effect of duloxetine combined with intrathecal morphine for patients subjected to major abdominal cancer surgery

Timeline

Start
2018-09-10
Primary completion
2020-03-10
Completion
2020-03-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg

Indications

No indication recorded.